Immunotherapy in Pediatric Hematologic Malignant Neoplasms
Childhood acute leukemia has achieved tremendous treatment outcome improvement over the past several decades. Given that pediatric leukemia remains the most common type of childhood malignant tumors, there are still unmet needs in relapsed/refractory diseases. Moreover, reducing the toxic adverse ef...
Saved in:
Main Author: | Kyung Taek Hong (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Pediatric Hematology-Oncology,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Immunotherapy for hematological malignancies in children
by: Yusi Zhou, et al.
Published: (2023) -
Viral etiology in pediatric hematological neoplasms
by: Abigail Morales-Sánchez, et al.
Published: (2016) -
The landscape overview of CD47-based immunotherapy for hematological malignancies
by: Hua Yang, et al.
Published: (2023) -
Editorial: Case reports in pediatric hematology and hematological malignancies 2022
by: Paulo S. S. Santos, et al.
Published: (2023) -
Pediatric solid malignant neoplasms: A comparative analysis
by: Bryan E Harmon, et al.
Published: (2011)